Onconetix Inc
ONCO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$719.93K
Close$
$13.27
313.5% upside
Current Fair Value
313.5% upsideUndervalued by 313.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $719,929.00 |
|---|---|
| Enterprise Value | $-5,035,192.00 |
| Earnings per Share | $-47.3 |
| Beta | 2.62 |
| Outstanding Shares | 224,277 |
Return
| Return on Equity | -75.70% |
|---|---|
| Return on Assets | -62.07% |
| Return on Invested Capital | -62.43% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -0.18 |
| Price to Sales | 1.61 |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | -5.05 |
| Enterprise Value to EBIT | 0.39 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.06 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 13, 2026
EPS Estimate
-$45050.00
Consensus analyst estimateRevenue Estimate
$17,455
Consensus analyst estimateNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-$450500.00
Consensus analyst estimateRevenue Estimate
$17,797
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.27%▲ 0.27% |
|---|---|
| Total Invested | $24,918 |
| Investors Holding | 5▲ 5.00% |
About Onconetix Inc
3 employees
developed by scientists at the prestigious oxford university in the uk, our vaccine protects against all influenza strains. it targets parts of the virus that are easy to induce a protective immune response against but also limited in...